2933399091
Anti cancer drug raw materials (gemcitabine, apatinib mesylate, sidabenamide, niraparib tosylate)
Applicable Value Added Tax Policy for Anti Cancer DrugsDeclaration Elements
0: Brand type
1: Export benefits situation
2: Ingredient content
3: Purpose:
4: Packaging specifications
5: Brand (Chinese or foreign name)
6: Model number
7: Signing Date
8:GTIN
9:CAS
10: Other
By each trade agreement
RCEP
Directory
CIQ
Jimetyrimidine, Apatinib Mesylate, Sidabenamide, and other anti-cancer drug raw materials (other hazardous chemicals)
Jimetyrimidine, Apatinib Mesylate, Sidabenamide, and other anti-cancer drug raw materials (other chemical products)
Anti cancer drug raw materials (gemcitabine, apatinib mesylate, sidabenamide, niraparib tosylate)
Disclaimer
The data on this page is sourced from publicly available information and is for reference only. It has no legal effect. Actual procedures should be based on the latest Import and Export Tariff Schedule and relevant laws and regulations issued by the General Administration of Customs.





